Xylem Inc.·4

Oct 21, 3:50 PM ET

Sabol Colin R 4

4 · Xylem Inc. · Filed Oct 21, 2021

Insider Transaction Report

Form 4
Period: 2021-10-19
Sabol Colin R
SVP & Chief Strategy Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-10-19$48.33/sh+1,900$91,82729,180 total
  • Sale

    Common Stock

    2021-10-19$125.82/sh1,900$239,06427,280 total
  • Exercise/Conversion

    Common Stock

    2021-10-19$48.33/sh+1,900$91,82729,180 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-10-191,9009,506 total
    Exercise: $48.33Exp: 2027-02-21Common (1,900 underlying)
  • Sale

    Common Stock

    2021-10-19$125.86/sh1,900$239,13427,280 total
  • Sale

    Common Stock

    2021-10-19$125.82/sh1,795$225,85325,485 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-10-191,9007,606 total
    Exercise: $48.33Exp: 2027-02-21Common (1,900 underlying)
Footnotes (5)
  • [F1]The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020.
  • [F2]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,756 Shares were executed at a range of prices from $125.32 to $126.26. 144 Shares were executed at a range of prices from $126.38 to $126.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  • [F3]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,808 Shares were executed at a range of prices from $125.31 to $126.26. 92 Shares were executed at a price of $126.56. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  • [F4]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,595 Shares were executed at a range of prices from $125.33 to $126.23. 200 Shares were executed at a range of prices from $126.36 to $126.42. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  • [F5]These options are fully vested and exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION